Published Date: 08 Mar 2023
A new review article titled "Cellular Aging: When Growth Stimuli Meet Cell Cycle Arrest" is published in Aging.
Read Full NewsIn a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.
A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
1.
Mutation Correlates with a Higher Prostate Cancer Mortality Risk.
2.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
3.
The diamonds that could find cancer
4.
Detecting invasive nodules could be key to preventing unnecessary pancreatic cancer surgery
5.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
1.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
2.
The Importance of Having a Quick and Effective Heparin Antidote
3.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
4.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation